1 unchanged sentence
The following exhibits are incorporated by reference or filed as part of this report.
−Removed: Amendment No.
−Removed: 1, dated May 30, 2020, to the License and Collaboration Agreement, dated April 11, 2016, by and between Intellia Therapeutics, Inc.
−Removed: and Regeneron Pharmaceuticals, Inc.
−Removed: Stock Purchase Agreement, dated May 30, 2020, by and between Intellia Therapeutics, Inc.
−Removed: and Regeneron Pharmaceuticals, Inc.
−Removed: Corporate Bonus Plan, effective April 3, 2020.
Certification of Chief Executive Officer pursuant to Rules 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
10 unchanged sentences
Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101.*) (1)
−Removed: Certain information in this exhibit was omitted by means of redacting a portion of the text and replacing it with “[***]”.
−Removed: The Registrant has determined that the omitted information (i) is not material and (ii) would be competitively harmful if publicly disclosed.
−Removed: Indicates a management contract or any compensatory plan, contract or arrangement.
−Removed: Incorporated by reference to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-37766) filed with the Securities and Exchange Commission on June 1, 2020.
Filed with this Quarterly Report on Form 10-Q.
2 unchanged sentences
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
−Removed: August 6, 2020
+Added: November 5, 2020
INTELLIA THERAPEUTICS, INC.
5 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.